COPE Advertising options


COPE Homepage Bottom of page Previous entry:
Next entry:
Random entry:
Search COPE:

Please donate

If COPE helps you,
please help me to continue my work.
Make a donation you can afford.


Return to entry tenascin-C

REFERENCES: Adams M et al Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Research 62(11): 3289-3297 (2002); Ambort D et al Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading. Matrix Biology 29(1): 31-42 (2010); Aukhil I et al Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. Journal of Biological Chemistry 268(4): 2542-2553 (1993); Bartsch S et al Expression of tenascin in the developing and adult cerebellar cortex (1992) Journal of Neuroscience 12(3): 736-749 (1992); Bell SC et al Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes. Molecular Human Reproduction 5(11): 1066-1076 (1999); Betz P et al Localization of tenascin in human skin wounds-an immunohistochemical study. International Journal of Legal Medicine 105: 325-328 (1993); Bourdon MA et al Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Research 43(6): 2796-2805 (1983); Bourdon MA et al Immunochemical and biochemical characterization of a glioma-associated extracellular matrix glycoprotein. Journal of Cellular Biochemistry 28(3): 183-195 (1985); Bourdon MA and Ruoslahti E Tenascin mediates cell attachment through an RGD-dependent receptor. Journal of Cell Biology 108(3): 1149-1155 (1989); Canfield AE and Schor AM Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. Journal of Cell Science 108(2): 797-809 (1995); Carnemolla B et al Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. American Journal of Pathology 154(5): 1345-1352 (1999); Cella N et al Lactogenic hormones and tenascin-C regulate C/EBPalpha and beta in mammary epithelial cells. Journal of Cellular Biochemistry 76(3): 394-403 (2000); Chen YJ et al Effects of cyclic mechanical stretching on the mRNA expression of tendon/ligament-related and osteoblast-specific genes in human mesenchymal stem cells. Connective Tissue Research 49(1): 7-14 (2008); Chiao YA et al In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics. Journal of Proteome Research 9(5): 2649-2657 (2010); Chiquet M Tenascin/J1/cytotactin: the potential function of hexabrachion proteins in neural development. Developmental Neuroscience 11(4-5): 266-275 (1989); Chiquet M et al Isolation of chick tenascin variants and fragments. A C-terminal heparin-binding fragment produced by cleavage of the extra domain from the largest subunit splicing variant. European Journal of Biochemistry 199(2): 379-388 (1991); Chiquet-Ehrismann R et al Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regulation 2(11): 927-938 (1991); Chiquet-Ehrismann R Tenascin and other adhesion-modulating proteins in cancer. Seminars in Cancer Biology 4(5): 301-310 (1993); Chiquet M and Fambrough DM Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. Journal of Cell Biology 98(6): 1926-1936 (1984); Chung CY et al Binding of tenascin-C to soluble fibronectin and matrix fibrils. Journal of Biological Chemistry 270(48): 29012-19017 (1995); Chung CY et al Mitogenesis, cell migration and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Molecular Biology of the Cell 7(6): 883-892 (1996); Chung CY and Erickson HP Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. Journal of Cell Biology 126(2): 539-548 (1994); Chuong CM and Chen HM Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. American Journal of Pathology 138: 427-440 (1991); Cifuentes-Diaz C et al The peripheral nerve and the neuromuscular junction are affected in the tenascin-C-deficient mouse. Cellular Molecular Biology (Noisy-le-grand). 1944(2): 357-379 (1998); Clark RA et al Tenascin supports lymphocyte rolling. Journal of Cell Biology 137(3): 755-765 (1997); Coughlin MD et al Determination of the molecular weight of neuronectin, a conditioned medium-derived, substrate-binding neurite-extension factor: comparison with laminin using radiation-inactivation analysis. Journal of Neuroscience 6(6): 1553-1559 (1986); Cowan KN et al Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. Journal of Clinical Investigation 105(1): 21-34 (2000); Cutolo M et al Tenascin and fibronectin distribution in human normal and pathological synovium. Journal of Rheumatology 19(9): 1439-1447 (1992); Day JM et al Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. Journal of Biological Chemistry 279(13): 12511-12518 (2004); de Chevigny A et al Delayed onset of odor detection in neonatal mice lacking tenascin-C. Molecular and Cellular Neurosciences 32(1-2): 174-186 (2006); Denda S et al Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. Biochemistry 37(16): 5464-5474 (1998); Derr LB et al The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation. 62(2): 71-82 (1997); d'Ortho MP et al Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. European Journal of Biochemistry 250(3): 751-757 (1997); Dueck M et al Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases. International Journal of Cancer 82(4): 477-483 (1999); Edelman GM and Jones FS Cytotactin: a morphoregulatory molecule and a target for regulation by homeobox gene products. Trends in Biochemical Sciences 17(6): 228-232 (1992); El-Karef A et al Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. Journal of Pathology 211(1): 86-94 (2007); Erickson HP Tenascin-C, tenascin-R, tenascin-X: a family of talented proteins in search of functions. Current Opinion in Cell Biology 5(5): 869-876 (1993); Erickson HP and Iglesias JL A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 311: 267-269 (1984); Erickson HP and Taylor HC Hexabrachion proteins in embryonic chicken tissues and human tumors. Journal of Cell Biology 105(3): 1387-1394 (1987); Faissner A et al The high-molecular-weight J1 glycoproteins are immunochemically related to tenascin. Differentiation 37(2): 104-114 (1988); Faissner A et al Binding of the J1 adhesion molecules to extracellular matrix constituents. Journal of Neurochemistry 54(3): 1004-1015 (1990); Faissner A and Kruse J J1/tenascin is a repulsive substrate for central nervous system neurons. Neuron 5(5): 627-637 (1990); Fassler R et al Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Experimental Cell Research 222: 111-116 (1996); Feng Y et al Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. Circulation Research 85(12): 1118-1123 (1999); Fischer D et al A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C. Journal of Biological Chemistry 270(7): 3378-3384 (1995); Forsberg E et al Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proceedings of the National Academy of Sciences (USA) 93(13): 6594-6599 (1996); Friedlander DR et al Functional mapping of cytotactin: proteolytic fragments active in cell-substrate adhesion. Journal of Cell Biology 107(6 Pt 1): 2329-2340 (1988); Galoian KA et al Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential. Experimental Biology and Medicine (Maywood) 232(4): 515-522 (2007); Garcion E et al Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration Development 128(13): 2485-2496 (2001); Garcion E et al Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131(14): 3423-3432 (2004); Garwood J et al The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor (2004) European Journal of Neuroscience 20(10): 2524-2540 (2004); Gherzi R et al Human tenascin gene. Structure of the 5′-region, identification, and characterization of the transcription regulatory sequences. Journal of Biological Chemistry 270(7): 3429-3434 (1995); Giese A et al Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. Journal of Cell Science 109(8): 2161-2168 (1996); Gštz M et al Tenascin-C synthesis and influence on axonal growth during rat cortical development. (1997) European Journal of Neuroscience 9(3): 496-506 (1997); Goh FG et al Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. Journal of Immunology 184(5): 2655-2662 (2010); Gong XG et al Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells. Biological and Pharmaceutical Bulletin 33(8): 1261-1267 (2010); Grumet M et al Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proceedings of the National Academy of Sciences (USA) 82(23): 8075-8079 (1985); Gulcher JR et al Chromosomal localization of the human hexabrachion (tenascin) gene and evidence for recent reduplication within the gene. Genomics 6(4): 616-622 (1990); Gulcher JR et al Structure of the human hexabrachion (tenascin) gene. Proceedings of the National Academy of Sciences (USA) 88(21): 9438-9442 (1991); Gundersen D et al Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. Journal of Immunology 158(3): 1051-1060 (1997); Gurevicius K et al Genetic ablation of tenascin-C expression leads to abnormal hippocampal CA1 structure and electrical activity in vivo. Hippocampus 19(12): 1232-1246 (2009); Hancox RA et al Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Research 11(2): R24 (2009); Hasaneen NA et al Cyclic mechanical strain-induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs. FASEB Journal 19(11): 1507-1509 (2005); Hauzenberger D et al Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin. European Journal of Immunology 29(5): 1435-1447 (1999); Hemesath TJ et al Inhibition of T cell activation by the extracellular matrix protein tenascin. Journal of Immunology 152(11): 5199-5207 (1994); Hibino S et al Tenascin suppresses CD3-mediated T cell activation. Biochemical Biophysical Research Communications 250(1): 119-124 (1998); Huang W et al Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Research 61(23): 8586-8594 (2001); Huang JY et al Extracellular Matrix of Glioblastoma Inhibits Polarization and Transmigration of T Cells: The Role of Tenascin-C in Immune Suppression. Journal of Immunology 185(3): 1450-1459 (2010); Ilunga K et al Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion. International Journal of Experimental Pathology 85(6): 373-379 (2004); Imai K et al Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Letters 352(2): 216-218 (1994); Imanaka-Yoshida K et al The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 71(4-5): 291-298 (2003); Imanaka-Yoshida K et al Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histology and Histopathology 19(2): 517-525 (2004); Ingham KC et al Localization of a cryptic binding site for tenascin on fibronectin. Journal of Biological Chemistry 279(27): 28132-28135 (2004); Iyer AK et al Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. Journal of Cellular Physiology 211(3): 748-758 (2007); Joester A and Faissner A The structure and function of tenascins in the nervous system (2001) Matrix Biology 20(1): 13-22 (2001); Joester A and Faissner A Evidence for Combinatorial Variability of Tenascin-C Isoforms and Developmental Regulation in the Mouse Central Nervous System (1999) Journal of Biological Chemistry 274(24): 17144-17151 (1999); Jones FS et al A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions. Proceedings of the National Academy of Sciences (USA) 86(6): 1905-1909 (1989); Jones PL and Jones FS Tenascin-C in development and disease: gene regulation and cell function. Matrix Biology 19(7): 581-596 (2000); Joshi P et al Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. Journal of Cell Science 106(1): 389-400 (1993); Kalembeyi I et al Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. International Journal of Cancer 105(1): 53-60 (2003); Kanayama M et al Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis. Journal of Immunology 182(12): 8015-8025 (2009); Kaplony A et al Tenascin Mr 220 000 isoform expression correlates with corneal cell migration. Development, 112(2): 605-614 (1991); Khan KM and Falcone DJ Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. Journal of Biological Chemistry 272(13): 8270-8275 (1997); Kiernan BW et al Myelination and behaviour of tenascin-C null transgenic mice. European Journal of Neuroscience 11(9): 3082-3092 (1999); KnŠuper V et al The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. Journal of Biological Chemistry 272(12): 7608-7616 (1997); Koyama Y et al Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. Journal of Investigative Dermatology 111(6): 930-935 (1998); Latijnhouwers MA et al Tenascin expression during wound healing in human skin. Journal of Pathology 178(1): 30-35 (1996); Latijnhouwers M et al Human epidermal keratinocytes are a source of tenascin-C during wound healing. Journal of Investigative Dermatology 108(5): 776-783 (1997); Latijnhouwers MA et al Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity. Archives of Dermatological Research 290(9): 490-496 (1998); Ljubimov AV et al Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. Investigative Ophthalmology and Visual Science 39(7): 1135-1142 (1998); Loike JD et al Blockade of alpha 5 beta 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins. Journal of Immunology 166(12): 7534-7542 (2001); Lundell A et al Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure 12(8): 1495-1506 (2004); Mackie EJ et al The distribution of tenascin coincides with pathways of neural crest migration. Development (Cambridge) 102: 237-250 (1988); Mackie EJ et al Induction of tenascin in healing wounds. Journal of Cell Biology 107(6 Pt 2): 2757-2767 (1988); Mai J et al Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas. Biological Chemistry 383(9): 1407-1413 (2002); Marton LS et al Binding of hexabrachions to heparin and DNA. Journal of Biological Chemistry 264(22): 13145-13149 (1989); Matsuda A et al Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Human Molecular Genetics 14(19): 2779-2786 (2005); Meiners S et al Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. Journal of Neuroscience 19(19): 8443-8453 (1999); Mercado ML et al Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediated by neuronal alpha7beta1 integrin. Journal of Neuroscience 24(1): 238-247 (2004); Midwood K et al Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nature Medicine 15(7): 774-780 (2009); Mighell AJ et al (1997) Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. International Journal of Cancer 72(2): 236-240 (1997); Murphy-Ullrich JE et al Focal adhesion integrity is downregulated by the alternatively spliced domain of tenascin. Journal of Cell Biology 115(4): 1127-1136 (1991); Nakahara H et al Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. European Journal of Immunology 36(12): 3334-3345 (2006); Nakao N et al Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. American Journal of Pathology 152(5): 1237-1245 (1998); Nies DE et al The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats. Journal of Biological Chemistry 266(5): 2818-2823 (1991); Nishiura R et al Expression of matrix metalloproteinase-3 in mouse endometrial stromal cells during early pregnancy: regulation by interleukin-1alpha and tenascin-C. Gynecological Endocrinology 21(2): 111-118 (2005); Orend G and Chiquet-Ehrismann R Tenascin-C induced signaling in cancer. Cancer Letters 244(2): 143-163 (2006); Parekh K et al Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes. Lung Cancer 47(1): 17-29 (2005); Pas J et al Analysis of structure and function of tenascin-C. International Journal of Biochemistry and Cell Biology 38(9): 1594-1602 (2006); Phillips GR et al Domains of tenascin involved in glioma migration. Journal of Cell Science 111(8): 1095-1104 (1998); Prieto AL et al Multiple integrins mediate cell attachment to cytotactin/tenascin. Proceedings of the National Academy of Sciences (USA) 90(21): 10154-10158 (1993); Probstmeier R and Pesheva P Tenascin-C inhibits beta1 integrin-dependent cell adhesion and neurite outgrowth on fibronectin by a disialoganglioside-mediated signaling mechanism. Glycobiology 9(2): 101-114 (1999); Puente Navazo MD et al The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production. Journal of Immunology 167(11): 6431-6440 (2001); Ramos DM et al Tenascin-C matrix assembly in oral squamous cell carcinoma. International Journal of Cancer75(5): 680-687 (1998); Richter P et al B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? Journal of Cancer Research and Clinical Oncology 135(10): 1351-1358 (2009); Rocchi M et al Assignment of the gene for human tenascin to the region q32-q34 of chromosome 9. Human Genetics 86(6): 621-623 (1991); Rźegg CR et al Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proceedings of the National Academy of Sciences (USA) 86(19): 7437-7441 (1989); Saga Y et al Mice develop normally without tenascin. Genes and Development 6(10): 1821-1831 (1992); Saghizadeh M et al Novel splice variants of human tenascin-C in normal and bullous keratopathy corneas. Cornea, 17(3): 326-332 (1998); Sahlberg C et al (2001) Tenascin-C in developing mouse teeth: expression of splice variants and stimulation by TGFbeta and FGF. European Journal of Oral Sciences 109(2): 114-124 (2001); Saito Y et al A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4. Journal of Biological Chemistry 282: 34929-34937 (2007); Saito Y et al Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins. Biological and Pharmaceutical Bulletin 31(5): 1003-1007 (2008); Saito Y et al Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4. Journal of Biological Chemistry 285(10): 7006-7015 (2010); Salter DM Tenascin is increased in cartilage and synovium from arthritic knees. British Journal of Rheumatology 32(9): 780-786 (1993); Sarkar S et al Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Research 66(24): 11771-11780 (2006); Schenk S et al The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Molecular Biology of the Cell 10(9): 2933-2943 (1999); Schnapp LM et al The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. Journal of Biological Chemistry 270(39): 23196-23202 (1995); Seiffert M et al Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated by various functional domains. Matrix Biology 17(1): 47-63 (1998); Siri A et al Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognised by two monoclonal antibodies. Nucleic Acids Research 19(3): 525-531 (1991); Siri A et al Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. Journal of Biological Chemistry 270(15): 8650-8654 (1995); Sriramarao P et al Endothelial cell attachment and spreading on human tenascin is mediated by 2β1 and vβ3 integrins. Journal of Cell Science 105(4): 1001-1012 (1993); Sriramarao P and Bourdon MA A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Research 21(1): 163-168 (1993); Steindler DA et al Tenascin knockout mice: barrels, boundary molecules, and glial scars. Journal of Neuroscience 15(3 Pt 1): 1971-1983 (1995); Stracke JO et al Biochemical characterization of the catalytic domain of human Matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. Journal of Biological Chemistry 275(20): 14809-14816 (2000); Swindle CS et al Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. Journal of Cell Biology 154(2): 459-468 (2001); Talts JF et al Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. Journal of Cell Science 112(12): 1855-1864 (1999); Taylor HC et al Biochemical and structural studies of tenascin/hexabrachion proteins. Journal of Cell Biology 41(2): 71-90 (1989); Thesleff I et al Molecular mechanisms of cell and tissue interactions during early tooth development. Anatomical Record 245(2): 151-161 (1996); Treloar HB et al Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. Journal of Neuroscience 29(30): 9405-9416 (2009); Tremble P et al The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Molecular Biology of the Cell 5(4): 439-453 (1994); Tucker RP Abnormal neural crest cell migration after the in vivo knockdown of tenascin-C expression with morpholino antisense oligonucleotides. Developmental Dynamics 222(1): 115-119 (2001); VŠŠnŠnen A et al Expression and regulation of MMP-20 in human tongue carcinoma cells. Journal of Dental Research 80(10): 1884-1889 (2001); Vollmer G et al Expression of tenascin-C by human endometrial adenocarcinoma and stromal cells: heterogeneity of splice variants and induction by TGF-beta. Biochemistry and Cell Biology 75(6): 759-769 (1997); von Holst A et al Neural Stem/Progenitor Cells Express 20 Tenascin C Isoforms That Are Differentially Regulated by Pax6 Journal of Biological Chemistry 282: 9172-9181 (2007); Wallner K et al EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arteriosclerosis Thrombosis and Vascular Biology 24(8): 1416-1421 (2004); Watanabe K et al Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin. Biochemistry 39: 7138-7144 (2000); Wilson KE et al Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. British Journal of Cancer 74(7): 999-1004 (1996); Yokosaki Y et al Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains. Journal of Biological Chemistry 271(39): 24144-24150 (1996); Yuasa S Development of astrocytes in the mouse embryonic cerebrum tracked by tenascin-C gene expression. Archives of Histology and Cytology 64(1): 119-126 (2001); Zagzag D et al Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Research 55(4): 907-914 (1995); Zagzag D et al Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Research 56(1): 182-189 (1996); Zisch AH et al Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains. Journal of Cell Biology 119(1): 203-213 (1992)

COPE Homepage Top of Page

SUPPORT COPE | Intro | Subdictionaries | New Entries | Contribute data | COPE Credentials
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Please inquire. COPE is interested in contacts with corporate sponsors appreciating and committed to communication biology

              Created, developed, and maintained by Prof Dr H Ibelgaufts              
About the author of COPE
  |    Contact COPE   |    Terms & Conditions

U L T R A   P O S S E   N E M O   O B L I G A T U R